236 related articles for article (PubMed ID: 24731971)
1. Application of physiologically-based toxicokinetic modelling in oral-to-dermal extrapolation of threshold doses of cosmetic ingredients.
Gajewska M; Worth A; Urani C; Briesen H; Schramm KW
Toxicol Lett; 2014 Jun; 227(3):189-202. PubMed ID: 24731971
[TBL] [Abstract][Full Text] [Related]
2. The margin of internal exposure (MOIE) concept for dermal risk assessment based on oral toxicity data - A case study with caffeine.
Bessems JGM; Paini A; Gajewska M; Worth A
Toxicology; 2017 Dec; 392():119-129. PubMed ID: 28288858
[TBL] [Abstract][Full Text] [Related]
3. Physiologically based toxicokinetic modelling as a tool to assess target organ toxicity in route-to-route extrapolation--the case of coumarin.
Mielke H; Abraham K; Götz M; Vieth B; Lampen A; Luch A; Gundert-Remy U
Toxicol Lett; 2011 Apr; 202(2):100-10. PubMed ID: 21291965
[TBL] [Abstract][Full Text] [Related]
4. In vitro-to-in vivo correlation of the skin penetration, liver clearance and hepatotoxicity of caffeine.
Gajewska M; Paini A; Sala Benito JV; Burton J; Worth A; Urani C; Briesen H; Schramm KW
Food Chem Toxicol; 2015 Jan; 75():39-49. PubMed ID: 25455898
[TBL] [Abstract][Full Text] [Related]
5. A generic, cross-chemical predictive PBTK model with multiple entry routes running as application in MS Excel; design of the model and comparison of predictions with experimental results.
Jongeneelen FJ; Berge WF
Ann Occup Hyg; 2011 Oct; 55(8):841-64. PubMed ID: 21998005
[TBL] [Abstract][Full Text] [Related]
6. The acute effects of daily nicotine intake on heart rate--a toxicokinetic and toxicodynamic modelling study.
Gajewska M; Worth A; Urani C; Briesen H; Schramm KW
Regul Toxicol Pharmacol; 2014 Oct; 70(1):312-24. PubMed ID: 25066669
[TBL] [Abstract][Full Text] [Related]
7. Simulation of urinary excretion of 1-hydroxypyrene in various scenarios of exposure to polycyclic aromatic hydrocarbons with a generic, cross-chemical predictive PBTK-model.
Jongeneelen F; ten Berge W
Int Arch Occup Environ Health; 2012 Aug; 85(6):689-702. PubMed ID: 22038087
[TBL] [Abstract][Full Text] [Related]
8. Assessing the safety of cosmetic chemicals: Consideration of a flux decision tree to predict dermally delivered systemic dose for comparison with oral TTC (Threshold of Toxicological Concern).
Williams FM; Rothe H; Barrett G; Chiodini A; Whyte J; Cronin MT; Monteiro-Riviere NA; Plautz J; Roper C; Westerhout J; Yang C; Guy RH
Regul Toxicol Pharmacol; 2016 Apr; 76():174-86. PubMed ID: 26825378
[TBL] [Abstract][Full Text] [Related]
9. Final report of the safety assessment of L-Ascorbic Acid, Calcium Ascorbate, Magnesium Ascorbate, Magnesium Ascorbyl Phosphate, Sodium Ascorbate, and Sodium Ascorbyl Phosphate as used in cosmetics.
Elmore AR
Int J Toxicol; 2005; 24 Suppl 2():51-111. PubMed ID: 16154915
[TBL] [Abstract][Full Text] [Related]
10. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
[TBL] [Abstract][Full Text] [Related]
11. Physiologically based toxicokinetic modelling of Tri(2-chloroethyl) phosphate (TCEP) in mice accounting for multiple exposure routes.
Ding J; He W; Sha W; Shan G; Zhu L; Zhu L; Feng J
Ecotoxicol Environ Saf; 2024 Feb; 271():115976. PubMed ID: 38232524
[TBL] [Abstract][Full Text] [Related]
12. Linking existing in vitro dermal absorption data to physicochemical properties: Contribution to the design of a weight-of-evidence approach for the safety evaluation of cosmetic ingredients with low dermal bioavailability.
Ates G; Steinmetz FP; Doktorova TY; Madden JC; Rogiers V
Regul Toxicol Pharmacol; 2016 Apr; 76():74-8. PubMed ID: 26807814
[TBL] [Abstract][Full Text] [Related]
13. Hydroquinone PBPK model refinement and application to dermal exposure.
Poet TS; Carlton BD; Deyo JA; Hinderliter PM
Food Chem Toxicol; 2010 Nov; 48(11):3085-92. PubMed ID: 20692312
[TBL] [Abstract][Full Text] [Related]
14. The contribution of dermal exposure to the internal exposure of bisphenol A in man.
Mielke H; Partosch F; Gundert-Remy U
Toxicol Lett; 2011 Jul; 204(2-3):190-8. PubMed ID: 21571050
[TBL] [Abstract][Full Text] [Related]
15. Comparison of PBTK model and biomarker based estimates of the internal dosimetry of acrylamide.
DeWoskin RS; Sweeney LM; Teeguarden JG; Sams R; Vandenberg J
Food Chem Toxicol; 2013 Aug; 58():506-21. PubMed ID: 23707562
[TBL] [Abstract][Full Text] [Related]
16. Risk assessment of skin lightening cosmetics containing hydroquinone.
Matsumoto M; Todo H; Akiyama T; Hirata-Koizumi M; Sugibayashi K; Ikarashi Y; Ono A; Hirose A; Yokoyama K
Regul Toxicol Pharmacol; 2016 Nov; 81():128-135. PubMed ID: 27521610
[TBL] [Abstract][Full Text] [Related]
17. Physiologically-based toxicokinetic modeling of human dermal exposure to diethyl phthalate: Application to health risk assessment.
Hu M; Zhang Y; Zhan M; He G; Qu W; Zhou Y
Chemosphere; 2022 Nov; 307(Pt 2):135931. PubMed ID: 35940406
[TBL] [Abstract][Full Text] [Related]
18. NTP technical report on the toxicity studies of p-tert-butylcatechol (CAS No. 98-29-3) administered in feed to F344/N rats and B6C3F1 mice.
Dunnick J
Toxic Rep Ser; 2002 Nov; (70):5-51. PubMed ID: 12592414
[TBL] [Abstract][Full Text] [Related]
19. PBTK model for assessment of operator exposure to haloxyfop using human biomonitoring and toxicokinetic data.
Cooper AB; Aggarwal M; Bartels MJ; Morriss A; Terry C; Lord GA; Gant TW
Regul Toxicol Pharmacol; 2019 Mar; 102():1-12. PubMed ID: 30543831
[TBL] [Abstract][Full Text] [Related]
20. Prediction of concentration-time profile and its inter-individual variability following the dermal drug absorption.
Polak S; Ghobadi C; Mishra H; Ahamadi M; Patel N; Jamei M; Rostami-Hodjegan A
J Pharm Sci; 2012 Jul; 101(7):2584-95. PubMed ID: 22517028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
